Molecular Templates, Inc. Annual report pursuant to Section 13 and 15(d)

Annual report pursuant to Section 13 and 15(d)

Net Loss Per Common Share (Tables)

Net Loss Per Common Share (Tables)

12 Months Ended

Dec. 31, 2014

Reconciliation of Numerator and Denominator

A reconciliation of the numerator and denominator used in the calculation is as follows (in thousands, except per share amounts):

	Years Ended December 31,
	2014			2013			2012
Numerator:
Net income (loss) - basic	$	(21,584	)	$	(28,415	)	$	(71,135	)
Less: noncash income from change in fair value of common stock warrants		9,344			—			—
Net loss - diluted		(30,928	)	$	(28,415	)	$	(71,135	)
Denominator:
Weighted-average number of common shares outstanding		60,335			57,832			54,219
Dilutive effect of warrants		3,051			—			—
Weighted-average common shares outstanding and dilutive potential common share-diluted		63,386			57,832			54,219
Net loss per share:
Basic	$	(0.36	)	$	(0.49	)	$	(1.31	)
Diluted	$	(0.49	)	$	(0.49	)	$	(1.31	)

Warrants, Options and Purchase Rights Excluded from Computation of Diluted Net Loss Per Common Share

The following warrants, outstanding options and purchase rights under the Company’s 2004 Employee Stock Purchase Plan (“2004 Purchase Plan”) were excluded from the computation of diluted net loss per common share for the periods presented because including them would have had an antidilutive effect (in thousands):

	Years Ended December 31,
	2014		2013		2012
Shares issuable upon exercise of warrants		—		8,282		11,583
Shares issuable upon exercise of stock options		8,169		6,527		5,099
Shares issuable related to the ESPP		67		64		79